Eyenovia Drug Patent Portfolio
Eyenovia owns 1 orange book drug protected by 3 US patents Given below is the list of Eyenovia's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10839960 | Ophthalmic drug delivery | 15 Jul, 2031 | Active |
| US11398306 | Ophthalmic drug delivery | 15 Jul, 2031 | Active |
| US11839487 | Ophthalmic drug delivery | 15 Jul, 2031 | Active |
Latest Legal Activities on Eyenovia's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Eyenovia.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Yr, Small Entity | 01 May, 2024 | US10839960 |
| Mail Patent eGrant Notification | 12 Dec, 2023 | US11839487 |
|
Email Notification
Critical
| 12 Dec, 2023 | US11839487 |
| Recordation of Patent eGrant | 12 Dec, 2023 | US11839487 |
|
Recordation of Patent Grant Mailed
Critical
| 12 Dec, 2023 | US11839487 |
| Patent eGrant Notification | 12 Dec, 2023 | US11839487 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 12 Dec, 2023 | US11839487 |
|
Email Notification
Critical
| 23 Nov, 2023 | US11839487 |
|
Issue Notification Mailed
Critical
| 22 Nov, 2023 | US11839487 |
| Dispatch to FDC | 02 Nov, 2023 | US11839487 |
|
Application Is Considered Ready for Issue
Critical
| 02 Nov, 2023 | US11839487 |
|
Issue Fee Payment Verified
Critical
| 01 Nov, 2023 | US11839487 |
|
Issue Fee Payment Received
Critical
| 01 Nov, 2023 | US11839487 |
| Supplemental Papers - Oath or Declaration | 23 Oct, 2023 | US11839487 |
|
Mail Notice of Allowance
Critical
| 06 Oct, 2023 | US11839487 |
Eyenovia's Family Patents
Eyenovia Drug List
Given below is the complete list of Eyenovia's drugs and the patents protecting them.
1. Mydcombi
Mydcombi is protected by 3 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10839960 | Ophthalmic drug delivery |
15 Jul, 2031
(5 years from now)
| Active |
| US11398306 | Ophthalmic drug delivery |
15 Jul, 2031
(5 years from now)
| Active |
| US11839487 | Ophthalmic drug delivery |
15 Jul, 2031
(5 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Mydcombi's drug page